Surmodics, Inc. (SRDX)
USD 39.7
(-0.65%)
USD 39.7
(-0.65%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 29.4 Million USD | 112.42% |
| 2022 | 13.84 Million USD | 38.43% |
| 2021 | 10 Million USD | 2193.58% |
| 2020 | 436 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 33.87 Million USD | 15.2% |
| 2024 Q3 | 33.45 Million USD | -0.62% |
| 2024 Q2 | 33.66 Million USD | -0.63% |
| 2023 Q3 | 33.45 Million USD | 14.18% |
| 2023 Q4 | 29.4 Million USD | -12.12% |
| 2023 FY | 29.4 Million USD | 112.42% |
| 2023 Q1 | 30.52 Million USD | 120.49% |
| 2023 Q2 | 29.3 Million USD | -3.99% |
| 2022 Q1 | 13.93 Million USD | 39.31% |
| 2022 Q2 | 15.06 Million USD | 8.12% |
| 2022 Q3 | 15 Million USD | -0.4% |
| 2022 Q4 | 13.84 Million USD | -7.72% |
| 2022 FY | 13.84 Million USD | 38.43% |
| 2021 Q1 | 456 Thousand USD | 4.59% |
| 2021 FY | 10 Million USD | 2193.58% |
| 2021 Q2 | 464 Thousand USD | 1.75% |
| 2021 Q4 | 10 Million USD | 1860.78% |
| 2021 Q3 | 510 Thousand USD | 9.91% |
| 2020 Q3 | 397 Thousand USD | 12.15% |
| 2020 Q2 | 354 Thousand USD | -25.0% |
| 2020 Q1 | 472 Thousand USD | 0.0% |
| 2020 FY | 436 Thousand USD | 0.0% |
| 2020 Q4 | 436 Thousand USD | 9.82% |
| 2019 Q3 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2006 Q3 | 1 Million USD | 0.0% |
| 2006 Q4 | - USD | -100.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2000 Q4 | - USD | -100.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q3 | 125 Thousand USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 541.67 Million USD | 94.572% |
| Nemaura Medical Inc. | 20.03 Million USD | -46.804% |
| NeuroPace, Inc. | 72.39 Million USD | 59.383% |
| LENSAR, Inc. | 2.3 Million USD | -1173.495% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | -300.286% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -1743.574% |
| Apyx Medical Corporation | 38.5 Million USD | 23.625% |
| Cutera, Inc. | 431.91 Million USD | 93.192% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | -88.096% |
| BioSig Technologies, Inc. | 452 Thousand USD | -6405.531% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 25.025% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 98.251% |
| Axonics, Inc. | 27.61 Million USD | -6.474% |
| IRIDEX Corporation | 2.74 Million USD | -970.83% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 62.874% |
| TELA Bio, Inc. | 42.78 Million USD | 31.265% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -7868.835% |
| RxSight, Inc. | 3.01 Million USD | -876.262% |
| Align Technology, Inc. | 96.96 Million USD | 69.676% |
| INVO Bioscience, Inc. | 8.68 Million USD | -238.628% |
| electroCore, Inc. | 626 Thousand USD | -4597.284% |
| Telesis Bio, Inc. | 34.38 Million USD | 14.471% |
| Viemed Healthcare, Inc. | 10.27 Million USD | -186.287% |
| Quipt Home Medical Corp. | 98.94 Million USD | 70.281% |
| Anika Therapeutics, Inc. | 29.03 Million USD | -1.267% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -1152.342% |
| Lucid Diagnostics Inc. | 15.25 Million USD | -92.756% |
| Dynatronics Corporation | 6.68 Million USD | -339.671% |
| Modular Medical, Inc. | 1.19 Million USD | -2371.008% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -11123.282% |
| Talis Biomedical Corporation | 19.66 Million USD | -49.507% |
| PetVivo Holdings, Inc. | 1.36 Million USD | -2054.149% |
| InMode Ltd. | 9.01 Million USD | -226.106% |
| Envoy Medical, Inc. | 404 Thousand USD | -7178.465% |
| Bruker Corporation | 1.37 Billion USD | 97.869% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -51487.719% |
| DexCom, Inc. | 2.59 Billion USD | 98.866% |
| Nexalin Technology, Inc. | 4463.00 USD | -658761.752% |
| PAVmed Inc | 48.72 Million USD | 39.651% |
| Viveve Medical, Inc. | 5.34 Million USD | -449.729% |
| Cerus Corporation | 95.99 Million USD | 69.369% |
| Movano Inc. | 252 Thousand USD | -11568.651% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 11.361% |
| Nexalin Technology, Inc. | 4463.00 USD | -658761.752% |
| IceCure Medical Ltd | 599 Thousand USD | -4809.015% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 92.926% |
| enVVeno Medical Corporation | 1.4 Million USD | -1997.361% |
| 908 Devices Inc. | 5.94 Million USD | -394.617% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | -110.925% |
| Orthofix Medical Inc. | 134.19 Million USD | 78.089% |
| Nuwellis, Inc. | 981 Thousand USD | -2897.452% |
| Outset Medical, Inc. | 136.18 Million USD | 78.409% |
| Venus Concept Inc. | 79.69 Million USD | 63.104% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 77.35% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 58.174% |
| Nano-X Imaging Ltd. | 8.39 Million USD | -250.226% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -3027.14% |
| Inogen, Inc. | 21.92 Million USD | -34.129% |
| IRadimed Corporation | 2.04 Million USD | -1339.275% |
| MaxCyte, Inc. | 18.74 Million USD | -56.885% |
| Pulmonx Corporation | 41.42 Million USD | 29.015% |
| PAVmed Inc. | 48.72 Million USD | 39.651% |
| iCAD, Inc. | 461 Thousand USD | -6278.525% |
| OrthoPediatrics Corp. | 23.76 Million USD | -23.758% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -1372.827% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -5876.735% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -15846.312% |
| SI-BONE, Inc. | 38.99 Million USD | 24.587% |
| Semler Scientific, Inc. | 70 Thousand USD | -41907.143% |
| Beyond Air, Inc. | 17.83 Million USD | -64.854% |
| FONAR Corporation | 41.67 Million USD | 29.444% |
| AxoGen, Inc. | 69.29 Million USD | 57.564% |
| Biotricity, Inc. | 23.87 Million USD | -23.143% |
| Cytosorbents Corporation | 18.31 Million USD | -60.568% |
| ZimVie Inc. | 521.92 Million USD | 94.366% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 41.628% |
| Inari Medical, Inc. | 32.04 Million USD | 8.244% |
| UFP Technologies, Inc. | 46.03 Million USD | 36.127% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -1372.827% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -857.486% |
| Sight Sciences, Inc. | 35.41 Million USD | 16.968% |
| Insulet Corporation | 1.44 Billion USD | 97.97% |
| Profound Medical Corp. | 7.9 Million USD | -272.198% |
| Bioventus Inc. | 409.47 Million USD | 92.819% |
| InspireMD, Inc. | 1.59 Million USD | -1743.574% |
| BrainsWay Ltd. | 471 Thousand USD | -6143.1% |
| BIOLASE, Inc. | 17.91 Million USD | -64.182% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -2737.395% |
| Tenon Medical, Inc. | 1.17 Million USD | -2406.82% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -2834.631% |
| CVRx, Inc. | 30.61 Million USD | 3.946% |
| AdaptHealth Corp. | 2.29 Billion USD | 98.719% |
| Sintx Technologies, Inc. | 4.24 Million USD | -592.697% |
| Acutus Medical, Inc. | 38.47 Million USD | 23.582% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -1373.935% |
| NanoVibronix, Inc. | 5000.00 USD | -588000.0% |
| Quanterix Corporation | 41.46 Million USD | 29.083% |
| LivaNova PLC | 640.4 Million USD | 95.408% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -883.258% |
| Varex Imaging Corporation | 469.5 Million USD | 93.737% |
| Vivani Medical, Inc. | 20.69 Million USD | -42.081% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -1152.342% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -3655.428% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 96.851% |
| TransMedics Group, Inc. | 515.94 Million USD | 94.301% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -1445.192% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -12107.526% |
| Spectral AI, Inc. | 1.28 Million USD | -2181.226% |
| Hyperfine, Inc. | 185 Thousand USD | -15794.595% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 84.703% |
| Biomerica, Inc. | 785 Thousand USD | -3645.86% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -6441.96% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -7845.043% |
| Silk Road Medical, Inc | 84.63 Million USD | 65.256% |